Compared to Estimates, MacroGenics (MGNX) Q2 Earnings: A Look at Key Metrics

MacroGenics (MGNX) reported $10.8 million in revenue for the quarter ended June 2024, representing a yearover-year decline of 17.8%. EPS of -$0.89 for the same period compares to -$0.36 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $24.14 million, representing a surprise of -55.28%. The company delivered an EPS surprise of -89.36%, with the consensus EPS estimate being -$0.47. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- a ...